Brief: Aytu Biopharma Inc - Quarterly Net Revenue Increased 53% Year-Over-Year To $23.1 Million
Feb 14 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA INC - QUARTERLY NET REVENUE INCREASED 53% YEAR-OVER-YEAR TO
$23.1
MILLION
* AYTU BIOPHARMA INC - NET LOSS FOR Q2 OF FISCAL YEAR 2022 WAS $11.5
MILLION, OR
$0.44 PER SHARE
Source: [https://bit.ly/36iULrf]
Further company coverage: AYTU.O
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations